Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTAP | Q13126 | 16/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067802 | 1.00 | MTAP (1.00) | MTAP | |
| SCHEMBL12715583 | 1.00 | MTAP (1.00) | MTAP | |
| SCHEMBL4736877 | 1.00 | MTAP (1.00) | MTAP | |
| SCHEMBL4752750 | 0.91 | MTAP (0.83) | MTAP | |
| SCHEMBL4736908 | 0.91 | MTAP (0.83) | MTAP | |
| SCHEMBL12945171 | 0.89 | MTAP (1.00) | MTAP | |
| SCHEMBL18975182 | 0.89 | MTAP (1.00) | MTAP | |
| SCHEMBL24063155 | 0.88 | MTAP (0.79) | MTAP | |
| SCHEMBL10064930 | 0.87 | MTAP (0.77) | MTAP | |
| SCHEMBL4736743 | 0.85 | MTAP (0.75) | MTAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11186575-B2 | Treatment of helicobacter pylori infections | Alber Einslein College of Medicine (US) | 2021-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11186575-B2 | Treatment of helicobacter pylori infections | MTAP, UNG, TPMT | MTAP 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.